tiprankstipranks
Trending News
More News >
Dawnrays Pharmaceutical Holdings Ltd. (HK:2348)
:2348
Hong Kong Market

Dawnrays Pharmaceutical Holdings Ltd. (2348) Income Statement

Compare
5 Followers

Dawnrays Pharmaceutical Holdings Ltd. Income Statement

Last quarter (Q2 2025), Dawnrays Pharmaceutical Holdings Ltd.'s total revenue was ¥630.42M, a decrease of -3.00% from the same quarter last year. In Q2, Dawnrays Pharmaceutical Holdings Ltd.'s net income was ¥104.57M. See Dawnrays Pharmaceutical Holdings Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.06B¥ 1.15B¥ 1.28B¥ 1.17B¥ 1.02B
Gross Profit
¥ 577.63M¥ 641.52M¥ 766.68M¥ 675.36M¥ 545.55M
Operating Expenses
¥ 209.72M¥ 199.20M¥ 344.27M¥ 293.47M¥ 223.83M
Depreciation and Amortization
¥ 78.44M¥ 83.89M¥ 66.41M¥ 53.13M¥ 59.58M
EBITDA
¥ 280.49M¥ 498.94M¥ 505.19M¥ 433.89M¥ 395.71M
Operating Income
¥ 367.91M¥ 277.42M¥ 422.41M¥ 380.76M¥ 320.50M
Other Income/Expenses
¥ 269.04M¥ 136.64M¥ 16.00M¥ 57.43M¥ 9.57M
Pretax Income
¥ 636.95M¥ 414.06M¥ 438.41M¥ 439.32M¥ 331.30M
Net Income
¥ 564.94M¥ 326.00M¥ 358.06M¥ 358.18M¥ 268.13M
Per Share Metrics
Basic EPS
¥ 0.38¥ 0.22¥ 0.24¥ 0.24¥ 0.17
Diluted EPS
¥ 0.38¥ 0.22¥ 0.24¥ 0.24¥ 0.17
Weighted Average Shares Outstanding
1.51B 1.50B 1.50B 1.50B 1.54B
Weighted Average Shares Outstanding (Diluted)
1.51B 1.50B 1.50B 1.51B 1.55B
Currency in CNY

Dawnrays Pharmaceutical Holdings Ltd. Earnings and Revenue History